Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

World Heart

This article was originally published in The Gray Sheet

Executive Summary

Ottawa, Ontario firm nets about $18 mil. from a secondary offering of 1.7 mil. shares at $11.35 each in conjunction with a concurrent offering of 255,000 shares by a selling shareholder. The deal is smaller than originally anticipated - 2 mil. shares by the company and 300,000 by the selling shareholder ("The Gray Sheet" May 3, p. 20). The first human implant of World Heart's HeartSaver ventricular assist device is expected by year-end, and proceeds from the offering are tabbed for continuing R&D, product development and commercialization. World Heart and the selling shareholder have granted overallotment options of 255,000 and 38,250 shares, respectively, to managers Merrill Lynch Canada, ScotiaMcLeod and CIBC World Markets, Inc
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT011819

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel